患者和公众参与研讨会,塑造人工智能支持的连接喘自我管理研究
Chi Yan Hui1, Ann Victoria Shenton1, Claire Martin1
1Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, United Kingdom.
PLOS digital health
|May 30, 2024
概括
患者参与开发人工智能驱动的喘管理数字健康工具至关重要. 共同设计的干预措施确保了可用性,并解决了患者的需求,导致更好的喘自我管理支持.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 医疗保健中的人工智能
- 喘管理的管理
背景情况:
- 使用人工智能的数字干预措施显示出降低喘恶化的前景.
- 患者参与对于确保数字健康工具的可用性至关重要.
- 连接喘 (C4A) 干预作为患者参与的案例研究.
研究的目的:
- 探索患者参与如何塑造人工智能驱动的喘数字干预的发展.
- 了解患者对人工智能交互,数据集成和喘管理工具所需功能的偏好.
主要方法:
- 七名患者和公众参与 (PPI) 的同事参加了四次咨询研讨会.
- 讨论的重点是首选的人工智能用例,好处,以及有关数据集成 (喘监测,环境数据) 的担忧.
- 关键主题包括人工智能用于数据收集,自我管理提醒,触发教育,风险识别和患者赋权.
主要成果:
- PPI的输入为下一个C4A干预的设计提供了信息,包括AI交互,功能和研究主题.
- 患者强调人工智能应该支持,而不是取代临床医生.
- 提出的关键问题包括健康不平等,数据呈现,准确性,隐私,安全和所有权.
结论:
- 患者角色可以从用户演变为数字健康发展中的共同设计合作伙伴.
- 技术创新者必须在整个开发周期内实施PPI的实际策略.
- 这种方法支持探索数字医疗实施的障碍,促进因素和优势.
更多相关视频
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
11.8K
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.2K
相关概念视频
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Inhaled Medications
252
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
252
